Our data provide evidence that PCK1 overexpression can inhibit tumor cell growth via down-regulation of UBAP2L Ser 454 phosphorylation and increasing autophagy, and that low PCK1 expression is an independent predictive factor for CRC recurrence and metastasis. Here, PCK1 is linked to colorectal carcinoma.